These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 996817)

  • 1. Effect of chlorphentermine on the lipids of rat lungs.
    Gloster J; Heath D; Hasleton P; Harris P
    Thorax; 1976 Oct; 31(5):558-64. PubMed ID: 996817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorphentermine-induced alterations in pulmonary phospholipid content in rats.
    Kacew S; Reasor MJ
    Biochem Pharmacol; 1983 Sep; 32(18):2683-8. PubMed ID: 6626239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced foam cell reactions in rats, II. Chemical analysis of lipids stored in lungs and foam cells after treatment with chlorphentermine, 5-[p-(fluoren-9-ylidenemethyl)phenyl]-2-piperidineethanol (RMI 10.393) and 1-chloramitriptyline.
    Karabelnik D; Zbinden G
    Hoppe Seylers Z Physiol Chem; 1975 Jul; 356(7):1151-60. PubMed ID: 1193539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chlorphentermine on incorporation of [14C]choline in the rat lung phospholipids.
    Gonmori K; Morita T; Mehendale HM
    Lipids; 1986 Mar; 21(3):230-4. PubMed ID: 3702614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palmitic acid-1-14C incorporation and turnover in lung phospholipids of rats treated with chlorphentermine, RMI 10.393 and Ro 4-4318.
    Karabelnik D; Zbinden G
    Arch Toxicol; 1976 Jun; 35(3):163-74. PubMed ID: 989288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in rat alveolar surfactant phospholipids and proteins induced by administration of chlorphentermine.
    Miles PR; Bowman L; Tucker J; Reasor MJ; Wright JR
    Biochim Biophys Acta; 1986 Jun; 877(1):167-78. PubMed ID: 3755061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gentamicin or chlorphentermine induction of phospholipidosis in the developing organism: role of tissue and species in manifestation of toxicity.
    Kacew S
    J Pharmacol Exp Ther; 1985 Jan; 232(1):239-43. PubMed ID: 3965695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. I. Drug and phospholipid levels.
    Heyneman CA; Reasor MJ
    J Pharmacol Exp Ther; 1986 Jan; 236(1):55-9. PubMed ID: 3941400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in newborn and adult rat lung morphology and phospholipid levels after chlorcyclizine or chlorphentermine treatment.
    Kacew S
    Toxicol Appl Pharmacol; 1982 Aug; 65(1):100-8. PubMed ID: 6128805
    [No Abstract]   [Full Text] [Related]  

  • 10. Impairment in pulmonary bioenergetics following chlorphentermine administration to rats.
    Zychlinski L; Montgomery MR; Shamblin PB; Reasor MJ
    Fundam Appl Toxicol; 1983; 3(3):192-8. PubMed ID: 6884634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced phospholipidosis. II. Alterations in the phospholipid pattern of organs from mice, rats and guinea-pigs after chronic treatment with chlorphentermine.
    Seiler KU; Wassermann O
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 288(2-3):261-8. PubMed ID: 1161047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of age in amphiphilic drug-induced pulmonary morphological and metabolic responses.
    Kacew S
    Fed Proc; 1984 Aug; 43(11):2592-6. PubMed ID: 6146538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of drug metabolism in protection against chlorphentermine-induced pulmonary phospholipidosis in adult rat.
    Kacew S; Narbaitz R; Ruddick JA; Villeneuve DC
    Exp Mol Pathol; 1981 Aug; 35(1):98-107. PubMed ID: 7250339
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of chlorphentermine-induced pulmonary phospholipidosis in rats by phenobarbital.
    Reasor MJ; Davis ME
    Drug Metab Dispos; 1985; 13(2):192-6. PubMed ID: 2859167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disaturated phosphatidylcholine in the pulmonary airspaces of rats treated with chlorphentermine.
    Reasor MJ; Heyneman CA
    Biochem Pharmacol; 1983 Mar; 32(5):939-41. PubMed ID: 6838642
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytochemical demonstration of increased phospholipid content in cell membranes in chlorphentermine-induced phospholipidosis.
    Coulombe PA; Bendayan M
    J Histochem Cytochem; 1989 Feb; 37(2):139-47. PubMed ID: 2911004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of drug-induced phospholipidosis on pulmonary disposition of pneumophilic drugs.
    Ohmiya Y; Angevine LS; Mehendale HM
    Drug Metab Dispos; 1983; 11(1):25-30. PubMed ID: 6132791
    [No Abstract]   [Full Text] [Related]  

  • 18. Morphological and biochemical alterations of the lung after application of chlorphentermine.
    Gräbner R; Meerbach W
    Exp Pathol (Jena); 1979; 17(6):303-11. PubMed ID: 527695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chlorphentermine pretreatment on the distribution of chlorphentermine in isolated perfused rat lungs.
    Angevine LS; Lockard VG; Mehendale HM
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 1):202-9. PubMed ID: 6724194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorphentermine-induced phospholipidosis in rat alveolar macrophages--luminol-dependent chemiluminescence.
    Reasor MJ
    Biochem Pharmacol; 1981 Jan; 30(2):165-8. PubMed ID: 7236305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.